Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Utilization of macrocyclic peptides to target protein-protein interactions in cancer. | Front Oncol | 2022 | 36465350 | PubTator, text mining | PubMed |
| SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity. | Sci Rep | 2022 | 36463361 | PubTator, text mining | PubMed |
| Pediatric meningioma with a Novel MAML2-YAP1 fusion variant: a case report and literature review. | BMC Pediatr | 2022 | 36463108 | PubTator, text mining | PubMed |
| Primary intraventricular synovial sarcoma of the brain with recurrence - case presentation. | BMC Neurol | 2022 | 36456921 | PubTator, text mining | PubMed |
| Detection of Bone Metastases by 68Ga-DOTA-SSAs and 18F-FDG PET/CT: A Two-Center Head-to-Head Study of Gastroenteropancreatic Neuroendocrine Neoplasms. | Contrast Media Mol Imaging | 2022 | 36447752 | PubTator, text mining | PubMed |
| Fluorescently Labeled Ceramides and 1-Deoxyceramides: Synthesis, Characterization, and Cellular Distribution Studies. | J Org Chem | 2022 | 36441972 | PubTator, text mining | PubMed |
| Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors. | Commun Biol | 2022 | 36435867 | PubTator, text mining | PubMed |
| Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary Update. | J Clin Med | 2022 | 36431313 | PubTator, text mining | PubMed |
| Impact of Diabetes Mellitus in Patients with Pancreatic Neuro-Endocrine Tumors: Causes, Consequences, and Future Perspectives. | Metabolites | 2022 | 36422243 | PubTator, text mining | PubMed |
| Rare pulmonary metastases of atypical meningioma diagnosed on total-body 18F-FDG PET/CT. | Am J Nucl Med Mol Imaging | 2022 | 36419587 | PubTator, text mining | PubMed |
| Current evidence on posthepatectomy liver failure: comprehensive review. | BJS Open | 2022 | 36415029 | PubTator, text mining | PubMed |
| Structure determination of inactive-state GPCRs with a universal nanobody. | Nat Struct Mol Biol | 2022 | 36396979 | PubTator, text mining | PubMed |
| Well-Differentiated Grade 3 Neuroendocrine Tumors: Characteristics, Treatments, and Outcomes From a Population-Based Study. | Pancreas | 2022 | 36395400 | PubTator, text mining | PubMed |
Progression of the tumor in a patient with a gastrointestinal stromal tumor with the PDGFRA exon 12 mutation who received multiple surgeries and multiple lines of tyrosine kinase inhibitor therapies: a case report. | J Gastrointest Oncol | 2022 | 36388657 | PubTator, text mining | PubMed |
| Abiraterone acetate for treatment of ectopic Cushing syndrome caused by ACTH-producing neuroendocrine tumor: a case report. | J Gastrointest Oncol | 2022 | 36388644 | PubTator, text mining | PubMed |
| The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next? | Front Endocrinol (Lausanne) | 2022 | 36387893 | PubTator, text mining | PubMed |
| Toward Personalized Medicine: One Chelator for Imaging and Therapy with Lutetium-177 and Actinium-225. | J Am Chem Soc | 2022 | 36382991 | PubTator, text mining | PubMed |
| Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency. | Nat Microbiol | 2022 | 36376394 | PubTator, text mining | PubMed |
| The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies. | Hum Vaccin Immunother | 2022 | 36369829 | PubTator, text mining | PubMed |
| Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer. | Pharmaceutics | 2022 | 36365249 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=41